News|Articles|October 30, 2026

LCGC eBooks

  • LCGC E-Books-2-10-2026
  • Volume Sponsored eBook

Characterizing GLP-1 Therapeutics: Analytical Challenges and Solutions NA

Semaglutide and tirzepatide are now household names, but behind every dose sits an analytical problem that small-molecule thinking can’t solve. Isomers share a mass, impurities hide in the tail of the main peak, and peptides cling to tubing, vials, and column hardware. Characterizing GLP-1 Therapeutics: Analytical Challenges and Solutions explores how separation scientists are responding. An expert Peer Exchange panel weighs up orthogonal methods, 2D-LC, inert hardware, and the role of AI in peptide method development. We trace the peptide revolution from Gila monster venom to a global surge in manufacturing capacity. And a new isocratic HPLC–DAD method shows that stability testing for both blockbuster peptides can be done in just three minutes.

Articles in this issue


Related to this article

Debunking Myths and Half-Truths in HPLC and Pharmaceutical Analysis
"Perspectives in HPLC" examines 5 long-held HPLC "rules" (mobile phase filtration, routine buffer use, avoiding pH near an analyte's pKa, defaulting to 4.6-mm columns, and relying on AI for early method development), showing with experimental evidence that each is conditional rather than universally true in modern small-molecule drug testing.